![](/img/cover-not-exists.png)
1226PA phase I clinical trial of malignant pleural mesothelioma treated with locally delivered autologous anti-FAP-targeted CAR T-cells
Curioni, A, Britschgi, C, Hiltbrunner, S, Bankel, L, Gulati, P, Weder, W, Opitz, I, Lauk, O, Caviezel, C, Knuth, A, Münz, C, Renner, C, Stahel, R A, Petrausch, UVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz253.052
Date:
October, 2019
File:
PDF, 74 KB
2019